IL2 and neoplasm: It is especially worth mentioning that those cell surface receptors are significantly upregulated on NK cells (i.e., CD56, CD94) of NSCLC patients in advanced tumor stages, which are also increased after stimulation with Hsp70-peptide TKD and IL-2 [32].